Ciara Curtin is a freelance science writer based in Atlanta. Her work focuses mostly on genetics and medicine. Ciara has an M.A. in molecular, cellular and developmental biology from the University of California, Santa Barbara, and one in journalism from New York University’s science writing program.
Ciara Curtin
From this contributor
Brain scans reveal subtypes of fragile X syndrome in boys
Differences in brain structure may distinguish boys with relatively mild features of fragile X syndrome from those with a severe form of the condition.
Brain scans reveal subtypes of fragile X syndrome in boys
By
Ciara Curtin
30 October 2017 | 4 min read
Data do-over backs dominance of genetics in autism risk
A reanalysis of data from more than 2 million children in Sweden suggests inherited genetic factors account for 83 percent of autism risk.
Data do-over backs dominance of genetics in autism risk
By
Ciara Curtin
19 October 2017 | 4 min read
Rat study ties Rett syndrome gene to pain processing
Mutations in MECP2, the gene mutated in Rett syndrome, may alter the proportions and activity of sensory neurons in rats.
Rat study ties Rett syndrome gene to pain processing
By
Ciara Curtin
21 September 2017 | 4 min read
Autism drugs may alter brain connectivity
Children with autism who take certain medications have different patterns of brain connectivity than do unmedicated children with the condition.
Twin tots reveal autism traits arise mostly from genes
Genes are bigger contributors to autism features than are environmental factors, according to a study of nearly 39,000 twins.
Twin tots reveal autism traits arise mostly from genes
By
Ciara Curtin
6 July 2017 | 3 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read